Write in a clean editor, then format for Japanese Journal of Clinical Oncology in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Japanese Journal of Clinical Oncology is a peer-reviewed journal published by Oxford University Press, covering Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Japanese Journal of Clinical Oncology, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — Japanese Journal of Clinical Oncology has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Gastric Cancer Management and Outcomes Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Head and Neck Cancer Studies Lung Cancer Research Studies |
| ISSN | 0368-2811 |
| Citation impact (2-yr) | 2.05 |
| h-index | 115 |
| i10-index | 3,211 |
| Total citations | 123,207 |
| Article processing charge | $3,300 |
| Top institutions publishing here | National Cancer Center |
| Journal website | jjco.oxfordjournals.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The Japan Cancer Surveillance Research Group aimed to estimate the cancer incidence in Japan in 2009 based on data collected from 32 of 37 population-based cancer registries, as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project. The incidence of only primary invasive cancer in Japan for 2009 was estimated to be 775…
The Japan Cancer Surveillance Research Group aimed to estimate the cancer incidence in Japan in 2008 based on data collected from 25 of 34 population-based cancer registries, as part of the Monitoring of Cancer Incidence in Japan project. The incidence in Japan for 2008 was estimated to be 749 767 (C00-C96). Stomach cancer and breast…
A randomized, controlled trial has begun to compare neoadjuvant chemotherapy using gemcitabine and S-1 with upfront surgery for patients planned resection of pancreatic cancer. Patients were enrolled after the diagnosis of resectable or borderline resectable by portal vein involvement pancreatic cancer with histological confirmation. They were randomly assigned to either neoadjuvant chemotherapy or upfront surgery.…
A Phase III study was started in Japan to evaluate the non-inferiority in overall survival of segmentectomy compared with lobectomy in patients with small-sized (diameter </=2 cm) peripheral non-small cell lung cancer, excluding radiologically determined non-invasive cancer. This study began in August 2009, and a total of 1100 patients will be accrued from 71 institutions…
BACKGROUND: Although the incidence and mortality of gastric cancer have gradually decreased, its burden remains in East Asian countries. Gastric cancer screening has been performed in Japan since 1983, and the introduction of new screening techniques has been eagerly anticipated. OBJECTIVE: To promote evidence-based screening, the Japanese guidelines for gastric cancer screening have been revised…
